Resistance To Breast Cancer Treatment Determined By Unsuspected Protein

An innovative research approach has identified a previously unsuspected protein as a key player in the resistance to particular forms of breast cancer therapy. The study, published by Cell Press in the February issue of Cancer Cell, significantly advances the understanding of the molecular response to breast cancer therapies that target estrogen signaling.Most breast tumors express estrogen receptor and are dependent on estrogen signaling.

More: continued here

Filed under: Breast Cancer on February 7th, 2008